G2 Buys Peyote-Focused Psychedelics Company Lophos Pharma
Greenridez 2.0 Acquisitions Corp. confirmed Friday that it has completed its acquisition of psychedelic research company Lophos Pharma, which is primarily concentrated on new therapeutic treatments derived from Peyote (Lophophora williamsii).
